Alkermes reiterates $400M-$420M Q4 proprietary net sales outlook while targeting mid-2027 alixorexton Phase III data

Seeking Alpha · 市场快讯 · November 3, 2026 at 7:17 PM ET

Read the full report at the original publisher.